Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2250242 | 1.00 | ALDH1A1 (0.31) | ALDH1A1CYP1A2 | |
| SCHEMBL11033434 | 0.80 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL11033431 | 0.80 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL81453 | 0.80 | MAPK1 (0.37) | ALDH1A1CYP1A2 | |
| SCHEMBL11030591 | 0.78 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL11030596 | 0.78 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL17241410 | 0.75 | — | — | |
| SCHEMBL755521 | 0.75 | — | — | |
| SCHEMBL29411187 | 0.75 | — | — | |
| SCHEMBL755520 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0045861-B1 | UNSATURATED COMPOUNDS, PROCESS FOR THEIR PREPARATION, THEIR USE AS PERFUMES AND THE PERFUMED COMPOSITIONS CONTAINING THEM | L. GIVAUDAN & CIE Société Anonyme (CH) | 1984-10-03 | — | — | EP | claimed |
| US-4426321-A | Odorant alkadienyl ketones, alcohols and oximes | GIVAUDAN CORPORATION (US) | 1984-01-17 | — | — | US | claimed |
| EP-0045861-A2 | Unsaturated compounds, process for their preparation, their use as perfumes and the perfumed compositions containing them | L. GIVAUDAN & CIE Société Anonyme (CH) | 1982-02-17 | — | — | EP | claimed |
| US-12371642-B2 | Benefit agent containing delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-29 | — | — | US | disclosed |
| US-20240316523-A1 | PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE | PROCTER & GAMBLE COMPANY, THE | 2024-09-26 | — | — | US | disclosed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | disclosed |
| US-11944727-B2 | Air freshening device | GIVAUDAN SA (CH) | 2024-04-02 | — | — | US | disclosed |
| EP-3310893-B2 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-02-28 | — | — | EP | disclosed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| EP-4288022-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| EP-0191365-B1 | ARALIPHATIC OXIMES, PROCESS FOR THEIR PRODUCTION AND PERFUME COMPOSITIONS CONTAINING SUCH COMPOUNDS | L. GIVAUDAN & CIE Société Anonyme (CH) | 1989-08-02 | — | — | EP | disclosed |
| US-4654169-A | ODORS OF BLACKCURRENT, SAGE, AND GRAPE | GIVAUDAN CORPORATION (US) | 1987-03-31 | — | — | US | disclosed |
| EP-0191365-A1 | Araliphatic oximes, process for their production and perfume compositions containing such compounds | L. GIVAUDAN & CIE Société Anonyme (CH) | 1986-08-20 | — | — | EP | disclosed |
| EP-0085352-B1 | UNSATURATED OXIMES, PREPARATION THEREOF AND USE THEREOF AS PERFUME AND IN THE FRAGMENT COMPOSITIONS | L. GIVAUDAN & CIE Société Anonyme (CH) | 1986-01-22 | — | — | EP | disclosed |
| US-4544714-A | PERFUMES | GIVAUDAN CORPORATION (US) | 1985-10-01 | — | — | US | disclosed |
| EP-0045861-B1 | UNSATURATED COMPOUNDS, PROCESS FOR THEIR PREPARATION, THEIR USE AS PERFUMES AND THE PERFUMED COMPOSITIONS CONTAINING THEM | L. GIVAUDAN & CIE Société Anonyme (CH) | 1984-10-03 | — | — | EP | disclosed |
| US-4426321-A | Odorant alkadienyl ketones, alcohols and oximes | GIVAUDAN CORPORATION (US) | 1984-01-17 | — | — | US | disclosed |
| EP-0085352-A2 | Unsaturated oximes, preparation thereof and use thereof as perfume and in the fragment compositions | L. GIVAUDAN & CIE Société Anonyme (CH) | 1983-08-10 | — | — | EP | disclosed |
| EP-0045861-A2 | Unsaturated compounds, process for their preparation, their use as perfumes and the perfumed compositions containing them | L. GIVAUDAN & CIE Société Anonyme (CH) | 1982-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | ALDH1A1 116/4885CYP1A2 70/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | ALDH1A1 413/4885CYP1A2 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.